Oestrogen receptor β: what it means for patients with breast cancer
2004
Summary Oestrogen receptor (ER)α is a well established prognostic marker in breast cancer, and all patients who are ER α positive receive tamoxifen as adjuvant endocrine therapy. Although ERα predicts a favourable disease outcome, the usefulness of ERβ as a clinical prognostic marker remains to be defined. Here, we outline the history of both ERs and discuss the implications ERβ has to patients with breast cancer.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
82
References
125
Citations
NaN
KQI